{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:06Z","timestamp":1740106926809,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010906","name":"NSAF Joint Fund","doi-asserted-by":"publisher","award":["81890994"],"award-info":[{"award-number":["81890994"]}],"id":[{"id":"10.13039\/501100010906","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00277-023-05112-w","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T16:48:33Z","timestamp":1675788513000},"page":"981-984","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia"],"prefix":"10.1007","volume":"102","author":[{"given":"Rong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yabin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingmin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kankan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"5112_CR1","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1038\/bcj.2015.95","volume":"5","author":"S Cerquozzi","year":"2015","unstructured":"Cerquozzi S, Tefferi A (2015) Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J 5:e366","journal-title":"Blood Cancer J"},{"key":"5112_CR2","doi-asserted-by":"crossref","unstructured":"Iurlo A, Cattaneo D, Gianelli U (2019) Blast transformation in myeloproliferative neoplasms: risk factors, biological findings, and targeted therapeutic options. Int J Mol Sci 20(8):1839","DOI":"10.3390\/ijms20081839"},{"issue":"23","key":"5112_CR3","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1056\/NEJMra063728","volume":"355","author":"PJ Campbell","year":"2006","unstructured":"Campbell PJ, Green AR (2006) The myeloproliferative disorders. N Engl J Med 355(23):2452\u20132466","journal-title":"N Engl J Med"},{"issue":"20","key":"5112_CR4","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1182\/blood-2013-06-510222","volume":"123","author":"J Li","year":"2014","unstructured":"Li J, Kent DG, Godfrey AL, Manning H, Nangalia J, Aziz A, Chen E, Saeb-Parsy K, Fink J, Sneade R et al (2014) JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease. Blood 123(20):3139\u20133151","journal-title":"Blood"},{"issue":"12","key":"5112_CR5","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1182\/blood-2007-07-099184","volume":"110","author":"G Barosi","year":"2007","unstructured":"Barosi G, Bergamaschi G, Marchetti M, Vannucchi AM, Guglielmelli P, Antonioli E, Massa M, Rosti V, Campanelli R, Villani L et al (2007) JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis. Blood 110(12):4030\u20134036","journal-title":"Blood"},{"issue":"1","key":"5112_CR6","first-page":"8","volume":"4","author":"TP Braun","year":"2015","unstructured":"Braun TP, Maxson JE, Agarwal A, Dunlap J, Spurgeon SE, Traer E (2015) Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome. Leuk Res Rep 4(1):8\u201311","journal-title":"Leuk Res Rep"},{"issue":"1","key":"5112_CR7","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1080\/16078454.2022.2153200","volume":"27","author":"YZ Jiang","year":"2022","unstructured":"Jiang YZ, Wei ZL, Wang NN, Huang C, Huang J, Yan JW, Wang R, Yu ZZ, Huang DP (2022) Clinical characteristics of a patient with de novo acute promyelocytic leukemia with JAK2 v617f mutation. Hematology 27(1):1290\u20131293","journal-title":"Hematology"},{"key":"5112_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.21037\/sci.2016.03.02","volume":"3","author":"A Mamorska-Dyga","year":"2016","unstructured":"Mamorska-Dyga A, Wu J, Khattar P, Ronny FM, Islam H, Seiter K, Liu D (2016) Acute promyelocytic leukemia co-existing with JAK2 V617F positive myeloproliferative neoplasm: a case report. Stem Cell Investig 3:8","journal-title":"Stem Cell Investig"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05112-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05112-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05112-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T21:14:21Z","timestamp":1678396461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05112-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["5112"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05112-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"assertion":[{"value":"15 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Xi\u2019an Gaoxin Hospital and with the 1964 Helsinki Declaration. The written informed consent was obtained from the enrolled participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}